In Might 2019, a trial at Nanjing University Healthcare facility commenced comparing dapagliflozin to liraglutide, and to the anti-diabetic medication acarbose, for their respective outcomes on cognitive and olfactory purpose in 87 overweight folks whose Form two diabetes is improperly controlled with metformin alone. The application for approval was supported https://6--hydroxy-paclitaxel35689.blog-eye.com/34887662/6α-hydroxy-paclitaxel-an-overview